UBC researchers have uncovered the cause of brain swelling after trauma to the head. Treatment options for brain swelling are currently limited, and although the technique used by the researchers to block swelling and cell death is unlikely to work quickly enough to mitigate swelling in the case of real head trauma, the discovery provides a target for drug development.
By turning off a single gene, scientists from the Djavad Mowafaghian Centre for Brain Health (DMCBH) were able to successfully stop swelling in rodent brains. Brain swelling is a gradual process that becomes life threatening within days of the injury, and is caused by sodium chloride drawing water into the nerve cells. This swelling (cytotoxic edema) eventually kills brain cells.
The team, including brain researcher Brian MacVicar, co-director of DMCBH with the Vancouver Coastal Health Research Institute and the study’s principal investigator; Terrance Snutch, director of translational neuroscience at the DMCBH; and Ravi Rungta, then a graduate student in the MacVicar lab and the lead author of the Cell article that reveals the findings, developed several novel technological approaches to identify the cascade of events that took place within individual brain cells as they swelled. They then switched off the expression of different genes and were able to pinpoint a single protein (SLC26A11) that acts as a channel for chloride to enter nerve cells. By turning off the chloride channel, the accumulation of fluid into the cells was halted, and nerve cells no longer died.
The Cell article is entitled “The cellular mechanisms of neuronal swelling underlying cytotoxic edema.” The research was co-sponsored by the Canadian Institutes of Health Research, Brain Canada, Genome British Columbia, the Michael Smith Foundation for Health Research, and the Koerner Foundation.
Above is the information needed to cite this article in your paper or presentation. The International Committee
of Medical Journal Editors (ICMJE) recommends the following citation style, which is the now nearly universally
accepted citation style for scientific papers:
Halpern SD, Ubel PA, Caplan AL, Marion DW, Palmer AM, Schiding JK, et al. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
About the ICMJE and citation styles
The ICMJE is small group of editors of general medical journals who first met informally in Vancouver, British Columbia, in 1978 to establish guidelines for the format of manuscripts submitted to their journals. The group became known as the Vancouver Group. Its requirements for manuscripts, including formats for bibliographic references developed by the U.S. National Library of Medicine (NLM), were first published in 1979. The Vancouver Group expanded and evolved into the International Committee of Medical Journal Editors (ICMJE), which meets annually. The ICMJE created the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals to help authors and editors create and distribute accurate, clear, easily accessible reports of biomedical studies.
An alternate version of ICMJE style is to additionally list the month an issue number, but since most journals use continuous pagination, the shorter form provides sufficient information to locate the reference. The NLM now lists all authors.
BCMJ standard citation style is a slight modification of the ICMJE/NLM style, as follows:
- Only the first three authors are listed, followed by "et al."
- There is no period after the journal name.
- Page numbers are not abbreviated.
For more information on the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, visit www.icmje.org